Pfizer wins EU approval for MabThera biosimilar

The drug will be available to treat certain cancers and autoimmune conditions

Read on PharmaTimes

Novartis, Incyte to test Jakavi for coronavirus-linked cytokine storm

Early clinical evidence suggests that the JAK inhibitor could reduce the number of patients requiring intensive care and mechanical ventilation

Read on PharmaTimes

Sanofi unveils new data for Dupixent in children with dermatitis

Nearly three times as many children achieved clear or almost clear skin when treated with Dupixent and standard-of-care topical corticosteroids

Read on PharmaTimes

Funding support for community pharmacy during coronavirus

The advanced funding injection is designed to support pharmacies to provide critical services throughout the pandemic

Read on PharmaTimes

Health secretary lays out plans for 100,000 coronavirus tests a day

Testing for those with a medical need and the most critical workers is to rise to 25,000 a day by mid-to-late April

Read on PharmaTimes

1 2 3

Top of page

Industry News

The drug will be available to treat certain cancers and autoimmune conditions.
Read More >

More Stories

News

Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >

More Stories

Latest Tweets

Follow Us